372
Views
0
CrossRef citations to date
0
Altmetric
Review

Illuminating the way: the role of bright light therapy in the treatment of depression

, , &
Pages 1157-1171 | Received 30 Jul 2023, Accepted 17 Oct 2023, Published online: 26 Oct 2023

References

  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders: 5th. Arlington (VA): American Psychiatric Association; 2013. doi: 10.1176/appi.books.9780890425596
  • Voineskos D, Daskalakis ZJ, Blumberger DM. Management of treatment-resistant depression: challenges and strategies. Neuropsychiatr Dis Treat. 2020;16:221–234. doi: 10.2147/NDT.S198774
  • Santomauro DF, Mantilla Herrera AM., Shadid J. COVID-19 mental disorders collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700–1712. doi: 10.1016/S0140-6736(21)02143-7
  • Di Bonaventura E M, Botticelli L, Del Bello F, et al. Investigating the role of the central melanocortin system in stress and stress-related disorders. Pharmacol Res. 2022;185: 106521. doi: 10.1016/j.phrs.2022.106521
  • Sagud M, Mihaljevic-Peles A, Uzun S, et al. The lack of association between components of metabolic syndrome and treatment resistance in depression. Psychopharmacol (Berl). 2013;230(1):15–21. doi: 10.1007/s00213-013-3085-x
  • Nuñez NA, Joseph B, Pahwa M, et al. Augmentation strategies for treatment resistant major depression: a systematic review and network meta-analysis. J Affect Disord. 2022;302:385–400. doi: 10.1016/j.jad.2021.12.134
  • Jha MK, Mathew SJ. Pharmacotherapies for treatment-resistant depression: how antipsychotics fit in the rapidly evolving therapeutic landscape. Am J Psychiatry. 2023;180(3):190–199. doi: 10.1176/appi.ajp.20230025
  • Idlett-Ali SL, Salazar CA, Bell MS, et al. Neuromodulation for treatment-resistant depression: functional network targets contributing to antidepressive outcomes. Front Hum Neurosci. 2023;17:1125074. doi: 10.3389/fnhum.2023.1125074
  • Vasiliu O. Esketamine for treatmentresistant depression: a review of clinical evidence (review). Exp Ther Med. 2023;25(3):111. doi: 10.3892/etm.2023.11810
  • Rhee TG, Shim SR, Forester BP, et al. Efficacy and safety of ketamine vs electroconvulsive therapy among patients with major depressive episode: a systematic review and meta-analysis. JAMA Psychiatry. 2022;79(12):1162–1172. doi: 10.1001/jamapsychiatry.2022.3352
  • Mure LS. Intrinsically photosensitive retinal ganglion cells of the human retina. Front Neurol. 2021;12:636330.
  • Li Y, Androulakis IP. Light entrainment of the SCN circadian clock and implications for personalized alterations of corticosterone rhythms in shift work and jet lag. Sci Rep. 2021;11(1):17929. doi: 10.1038/s41598-021-97019-7
  • Maruani J, Anderson G, Etain B, et al. The neurobiology of adaptation to seasons: relevance and correlations in bipolar disorders. Chronobiol Int. 2018;35(10):1335–1353. doi: 10.1080/07420528.2018.1487975
  • Arendt J, Aulinas A Physiology of the pineal gland and melatonin. Endotext [Internet]. MDText.com, Inc.; 2022 [cited 2023 Jun 19]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK550972/PMID:31841296
  • Loving RT, Kripke DF, Elliott JA, et al. Bright light treatment of depression for older adults. BMC Psychiatry. 2005;5(1):41. doi: 10.1186/1471-244X-5-41
  • Spitschan M, Santhi N. Individual differences and diversity in human physiological responses to light. EBioMedicine. 2022;75:103640. doi: 10.1016/j.ebiom.2021.103640
  • Vetter C, Pattison PM, Houser K, et al. A review of human physiological responses to light: implications for the development of integrative lighting solutions. LEUKOS. 2022;18(3):387–414. doi: 10.1080/15502724.2021.1872383
  • Rodgers J, Peirson SN., Hughes S, et al. Functional characterisation of naturally occurring mutations in human melanopsin. Cell Mol Life Sci. 2018;75(19):3609–3624. doi: 10.1007/s00018-018-2813-0
  • Adamsson M, Laike T, Morita T. Annual variation in daily light exposure and circadian change of melatonin and cortisol concentrations at a northern latitude with large seasonal differences in photoperiod length. J Physiol Anthropol. 2016;36(1):6. doi: 10.1186/s40101-016-0103-9
  • Roecklein KA, Franzen PL, Wescott DL, et al. Melanopsin-driven pupil response in summer and winter in unipolar seasonal affective disorder. J Affect Disord. 2021;291:93–101. doi: 10.1016/j.jad.2021.04.084
  • Eto T, Ohashi M, Nagata K, et al. Crystalline lens transmittance spectra and pupil sizes as factors affecting light-induced melatonin suppression in children and adults. Ophthalmic Physiol Opt. 2021;41(4):900–910. doi: 10.1111/opo.12809
  • McGlashan EM, Coleman MY, Vidafar P, et al. Decreased sensitivity of the circadian system to light in current, but not remitted depression. J Affect Disord. 2019;256:386–392. doi: 10.1016/j.jad.2019.05.076
  • Vidafar P, Spitschan M. Light on shedding: a review of sex and menstrual cycle differences in the physiological effects of light in humans. J Biol Rhythms. 2023;38(1):15–33. doi: 10.1177/07487304221126785
  • Mure LS, Vinberg F, Hanneken A, et al. Functional diversity of human intrinsically photosensitive retinal ganglion cells. Science. 2019;366: 1251–1255. doi: 10.1126/science.aaz0898
  • Fernandez DC, Fogerson PM, Lazzerini Ospri L, et al. Light affects mood and learning through distinct retina-brain pathways. Cell. 2018;175(1):71–84.e18. doi: 10.1016/j.cell.2018.08.004
  • Amidfar M, Garcez ML, Kim YK. The shared molecular mechanisms underlying aging of the brain, major depressive disorder, and Alzheimer’s disease: the role of circadian rhythm disturbances. Prog Neuropsychopharmacol Biol Psychiatry. 2023;123:110721. doi: 10.1016/j.pnpbp.2023.110721
  • Hoyos CM, Gordon C, Terpening Z, et al. Circadian rhythm and sleep alterations in older people with lifetime depression: a case-control study. BMC Psychiatry. 2020;20(1):192. doi: 10.1186/s12888-020-02606-z
  • Kim MJ, Lee JH, Duffy JF. Circadian rhythm sleep disorders. J Clin Outcomes Managment. 2013;20(11):513–528.
  • Youngstedt SD, Elliott JA, Kripke DF. Human circadian phase-response curves for exercise. J Physiol. 2019;597(8):2253–2268. doi: 10.1113/JP276943
  • Sit DK, McGowan J, Wiltrout C, et al. Adjunctive bright light therapy for bipolar depression: a randomized double-blind placebo-controlled trial. Am J Psychiatry. 2018;175(2):131–139. doi: 10.1176/appi.ajp.2017.16101200
  • Lewy AJ, Lefler BJ, Emens JS, et al. The circadian basis of winter depression. Proc Natl Acad Sci USA. 2006;103(19):7414–7419. doi: 10.1073/pnas.0602425103
  • Zimmet P, Alberti KGMM, Stern N, et al. The circadian syndrome: is the metabolic syndrome and much more! J Intern Med. 2019;286(2):181–191. doi: 10.1111/joim.12924
  • Bilu C, Einat H, Zimmet P, et al. Beneficial effects of daytime high-intensity light exposure on daily rhythms, metabolic state and affect. Sci Rep. 2020;10(1):19782. doi: 10.1038/s41598-020-76636-8
  • Campbell PD, Miller AM, Woesner ME. Bright light therapy: seasonal affective disorder and beyond. Einstein J Biol Med. 2017;32:E13–E25. PMCID: PMC6746555. doi: 10.1016/j.jad.2016.03.016
  • Vahid-Ansari F, Albert PR. Rewiring of the serotonin system in major depression. Front Psychiatry. 2021;12:802581. doi: 10.3389/fpsyt.2021.802581
  • Tyrer AE, Levitan RD, Houle S, et al. Serotonin transporter binding is reduced in seasonal affective disorder following light therapy. Acta Psychiatr Scand. 2016;134(5):410–419. doi: 10.1111/acps.12632
  • Lavoie MP, Lam RW, Bouchard G, et al. Evidence of a biological effect of light therapy on the retina of patients with seasonal affective disorder. Biol Psychiatry. 2009;66(3):253–258. doi: 10.1016/j.biopsych.2008.11.020
  • Najjar R.P., Zeitzer JM. Temporal integration of light flashes by the human circadian system. J Clin Invest. 2016;126(3):938–947. doi: 10.1172/JCI82306
  • Blagonravov ML, Bryk AA, Goryachev VA, et al. Bright light therapy increases blood pressure and changes the structure of circadian rhythm of melatonin secretion in spontaneously hypertensive rats. Bull Exp Biol Med. 2019;168(2):214–218. doi: 10.1007/s10517-019-04677-9
  • Blume C, Garbazza C, Spitschan M. Effects of light on human circadian rhythms, sleep and mood. Somnologie (Berl). 2019;23(3):147–156. doi: 10.1007/s11818-019-00215-x
  • Coburn KL, Lauterbach EC, Boutros NN, et al. The value of quantitative electroencephalography in clinical psychiatry: a report by the committee on research of the American neuropsychiatric association. J Neuropsychiatry Clin Neurosci. 2006;18(4):460–500. doi: 10.1176/jnp.2006.18.4.460
  • Begić D, Popović-Knapić V, Grubišin J, et al. Quantitative electroencephalography in schizophrenia and depression. Psychiatry Danub. 2011;23(4):355–362.
  • Makris GD, Reutfors J, Larsson R, et al. Serotonergic medication enhances the association between suicide and sunshine. J Affect Disord. 2016;189:276–281. doi: 10.1016/j.jad.2015.09.056
  • Nedic Erjavec G, Sagud M, Nikolac Perkovic M, et al. Depression: biological markers and treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2021;105: 110139. doi: 10.1016/j.pnpbp.2020.110139
  • Gubin D, Weinert D. Melatonin, circadian rhythms and glaucoma: current perspective. Neural Regen Res. 2022;17(8):1759–1760. doi: 10.4103/1673-5374.332149
  • Gubin DG, Malishevskaya TN, Astakhov YS, et al. Progressive retinal ganglion cell loss in primary open-angle glaucoma is associated with temperature circadian rhythm phase delay and compromised sleep. Chronobiology Int. 2019;36(4):564–577. doi: 10.1080/07420528.2019.1566741
  • Gubin D, Neroev V, Malishevskaya T, et al. Melatonin mitigates disrupted circadian rhythms, lowers intraocular pressure, and improves retinal ganglion cells function in glaucoma. J Pineal Res. 2021;70: e12730. doi: 10.1111/jpi.12730
  • Gubin D, Neroev V, Malishevskaya T, et al. Depression scores are associated with retinal ganglion cells loss. J Affect Disord. 2023;333:290–296. doi: 10.1016/j.jad.2023.04.039
  • Nikolac Perkovic M, Gredicak M, Sagud M, et al. The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression. Expert Rev Mol Diagn. 2023;23(4):283–296. doi: 10.1080/14737159.2023.2200937
  • Tirassa P, Iannitelli A, Sornelli F, et al. Daily serum and salivary BDNF levels correlate with morning-evening personality type in women and are affected by light therapy. Riv Psichiatr. 2012;47(6):527–534. doi: 10.1708/1178.13059
  • Normann AJ The Effect of Light Therapy and Acute Aerobic Exercise on Serum Brain Derived Neurotrophic Factor in Older Adults [ master’s thesis]. Long Beach (CA): California State University; 2020.
  • Molendijk ML, Haffmans JP, Bus BA, et al. Serum BDNF concentrations show strong seasonal variation and correlations with the amount of ambient sunlight. PLoS One. 2012;7(11):e48046. doi: 10.1371/journal.pone.0048046
  • Huang X, Huang Y, Hu B. Melatonin treatment of circadian rhythm sleep-wake disorder in obese children affects the brain-derived neurotrophic factor level. Neuropediatrics. 2023;54(4):260–265. doi: 10.1055/s-0042-1760368
  • Kosanovic Rajacic B, Sagud M, Begic D, et al. Plasma brain-derived neurotrophic factor levels in first-episode and recurrent major depression and before and after bright light therapy in treatment-resistant depression. Biomolecules. 2023;13(9):1425. doi: 10.3390/biom13091425
  • Spies M, James GM, Vraka C, et al. Brain monoamine oxidase a in seasonal affective disorder and treatment with bright light therapy. Transl Psychiatry. 2018;8(1):198. doi: 10.1038/s41398-018-0227-2
  • Maruani J, Geoffroy PA. Multi-level processes and retina-brain pathways of photic regulation of mood. J Clin Med. 2022;11(2):448. doi: 10.3390/jcm11020448
  • Aan Het Rot M, Benkelfat C, Boivin DB, et al. Bright light exposure during acute tryptophan depletion prevents a lowering of mood in mildly seasonal women. Eur Neuropsychopharmacol. 2008;18(1):14–23. doi: 10.1016/j.euroneuro.2007.05.003
  • Neumeister A, Turner EH, Matthews JR, et al. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch Gen Psychiatry. 1998;55(6):524–530. doi: 10.1001/archpsyc.55.6.524
  • Hu H, Cui Y, Yang Y. Circuits and functions of the lateral habenula in health and in disease. Nat Rev Neurosci. 2020;21:277–295. doi: 10.1038/s41583-020-0292-4
  • Ables JL, Park K, Ibañez-Tallon I. Understanding the habenula: a major node in circuits regulating emotion and motivation. Pharmacol Res. 2023;190:106734. doi: 10.1016/j.phrs.2023.106734
  • Webster JF, Lecca S, Wozny C. Inhibition within the lateral habenula-implications for affective disorders. Front Behav Neurosci. 2021;26(15):786011. doi: 10.3389/fnbeh.2021.786011
  • Huang L, Xi Y, Peng Y, et al. A visual circuit related to habenula underlies the antidepressive effects of light therapy. Neuron. 2019;102(1):128–142. doi: 10.1016/j.neuron.2019.01.037
  • Wirz-Justice A, Terman AM. CME: light therapy: why, what, for whom, how, and when (and a postscript about darkness). Praxis (Bern 1994). 2022;110(2):56–62. doi: 10.1024/1661-8157/a003821
  • Chojnacka M, Antosik-Wójcińska AZ, Dominiak M, et al. A sham-controlled randomized trial of adjunctive light therapy for non-seasonal depression. J Affect Disord. 2016;203:1–8. doi: 10.1016/j.jad.2016.05.062
  • Perera S, Eisen R, Bhatt M, et al. Light therapy for non-seasonal depression: systematic review and meta-analysis. BJ Psych Open. 2016;2(2):116–126. doi: 10.1192/bjpo.bp.115.001610
  • Maruani J, Geoffroy PA. Bright light as a personalized precision treatment of mood disorders. Front Psychiatry. 2019;10:85.
  • Lam RW, Levitt AJ, Levitan RD, et al. Efficacy of bright light treatment, fluoxetine, and the combination in patients with non-seasonal major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2016;73(1):56–63. doi: 10.1001/jamapsychiatry.2015.2235
  • Even C, Schroder CM, Friedman S, et al. Efficacy of light therapy in non-seasonal depression: a systematic review. J Affect Disord. 2008;108: 11–23. doi: 10.1016/j.jad.2007.09.008
  • Yorguner Kupeli N, Bulut NS, Carkaxhiu Bulut G, et al. Efficacy of bright light therapy in bipolar depression. Psychiatry Res. 2018;260:432–438. doi: 10.1016/j.psychres.2017.12.020
  • Tao L, Jiang R, Zhang K, et al. Light therapy in non-seasonal depression: an update meta-analysis. Psychiatry Res. 2020;291:113247. doi: 10.1016/j.psychres.2020.113247
  • Meesters Y, Dekker V, Schlangen LJ, et al. Low-intensity blue-enriched white light (750 lux) and standard bright light (10000 lux) are equally effective in treating SAD. A randomized controlled study. BMC Psychiatry. 2011;11: 17. doi: 10.1186/1471-244X-11–17
  • Brainard GC, Hanifin JP, Greeson JM, et al. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci. 2001;21(16):6405–6412. doi: 10.1523/JNEUROSCI.21-16-06405.2001
  • Do A, Li VW, Huang S, et al. Blue-light therapy for seasonal and non-seasonal depression: a systematic review and meta-analysis of randomized controlled trials. Can J Psychiatry. 2022;67(10):745–754. doi: 10.1177/07067437221097903
  • Al-Karawi D, Jubair L. Bright light therapy for nonseasonal depression: meta-analysis of clinical trials. J Affect Disord. 2016;198:64–71. doi: 10.1016/j.jad.2016.03.016
  • Geoffroy PA, Schroder CM, Reynaud E, et al. Efficacy of light therapy versus antidepressant drugs, and of the combination versus monotherapy, in major depressive episodes: a systematic review and meta-analysis. Sleep Medicine Reviewsquery. 2019;48:101213. doi: 10.1016/j.smrv.2019.101213
  • Penders TM, Stanciu CN, Schoemann AM, et al. Bright light therapy as augmentation of pharmacotherapy for treatment of depression: a systematic review and meta-analysis. Prim Care Companion CNS Disord. 2016;18(5). doi: 10.4088/PCC.15r01906
  • Zhao X, Ma J, Wu S, et al. Light therapy for older patients with non-seasonal depression: a systematic review and meta-analysis. J Affect Disord. 2018;232:291–299. doi: 10.1016/j.jad.2018.02.041
  • Demirkol ME, Namli Z, Tamam L. Efficacy of light therapy on non-seasonal depression and inflammatory markers. Europ J Psychiat. 2019;33(3):104–111. doi: 10.1016/j.ejpsy.2019.03.002
  • Baldessarini RJ, Vázquez GH, Tondo L. Bipolar depression: a major unsolved challenge. Int J Bipolar Disord. 2020;8(1):1. doi: 10.1186/s40345-019-0160-1
  • Hirakawa H, Terao T, Muronaga M, et al. Adjunctive bright light therapy for treating bipolar depression: a systematic review and meta-analysis of randomized controlled trials. Brain Behav. 2020;10(12):e01876. doi: 10.1002/brb3.1876
  • Tseng PT, Chen YW, Tu KY, et al. Light therapy in the treatment of patients with bipolar depression: a meta-analytic study. Eur Neuropsychopharmacol. 2016;26(6):1037–1047. doi: 10.1016/j.euroneuro.2016.03.001
  • Golden RN, Gaynes BN, Ekstrom RD, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatr. 2005;162(4):656–662. doi: 10.1176/appi.ajp.162.4.656
  • Danilenko KV, Lebedinskaia MY, Gadetskaia EV, et al. A 6-day combined wake and light therapy trial for unipolar depression. J Affect Disord. 2019;259:355–361. doi: 10.1016/j.jad.2019.08.051
  • Geoffroy PA, Palagini L. Biological rhythms and chronotherapeutics in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2021;106:110158. doi: 10.1016/j.pnpbp.2020.110158
  • Fritzsche M, Heller R, Hill H, et al. Sleep deprivation as a predictor of response to light therapy in major depression. J Affect Disord. 2001;62(3):207–215. doi: 10.1016/S0165-0327(00)00154-3
  • Li F, Nasir M, Olten B, et al. Meta-analysis of placebo response in adult antidepressant trials. CNS Drugs. 2019;33(10):971–980. doi: 10.1007/s40263-019-00662-y
  • Razza LB, Moffa AH, Moreno ML, et al. A systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trials. Prog Neuropsychopharmacol Biol Psychiatry. 2018;81: 105–113. doi: 10.1016/j.pnpbp.2017.10.016
  • Jones B.D.M, Razza L.B, Weissman C.R, et al. Magnitude of the placebo response across treatment modalities used for treatment-resistant depression in adults: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(9):e2125531. doi: 10.1001/jamanetworkopen.2021.25531
  • Kirsch I. Antidepressants and the placebo effect. Z Psychol. 2014;222(3):128–134. doi: 10.1027/2151-2604/a000176
  • Chen IP, Huang CC, Huang HC, et al. Adjunctive bright light therapy for non-seasonal major depressive disorder: a randomized controlled trial. Int J Environ Res Public Health. 2022;19(19):12430. doi: 10.3390/ijerph191912430
  • Garbazza C, Cirignotta F, D’Agostino A, et al. “Life-ON” study group. Sustained remission from perinatal depression after bright light therapy: a pilot randomised, placebo-controlled trial. Acta Psychiatr Scand. 2022;146(4):350–356. doi: 10.1111/acps.13482
  • Donmez M, Yorguner N, Kora K, et al. Efficacy of bright light therapy in perinatal depression: a randomized, double-blind, placebo-controlled study. J Psychiatr Res. 2022;149:315–322. doi: 10.1016/j.jpsychires.2022.02.027
  • Bais B, Kamperman AM, Bijma HH, et al. Effects of bright light therapy for depression during pregnancy: a randomised, double-blind controlled trial. BMJ Open. 2020;10(10):e038030. doi: 10.1136/bmjopen-2020-038030
  • Brouwer A, van Raalte DH, Nguyen HT, et al. Effects of light therapy on mood and insulin sensitivity in patients with type 2 Diabetes and depression: results from a randomized placebo-controlled trial. Diabetes Care. 2019;42(4):529–538. doi: 10.2337/dc18-1732
  • Wirz-Justice A, Bader A, Frisch U, et al. A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression. J Clin Psychiatry. 2011;72(7):986–993. doi: 10.4088/JCP.10m06188blu
  • Levitt AJ, Joffe RT, Kennedy SH. Bright light augmentation in antidepressant non-responders. J Clin Psychiatry. 1991;52(8): 336–337. PMID: 1869495.
  • Prasko J, Brunovsky M, Latalova K, et al. Augmentation of antidepressants with bright light therapy in patients with comorbid depression and borderline personality disorder. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010;154(4):355–361. doi: 10.5507/bp.2010.053
  • Echizenya M, Suda H, Takeshima M, et al. Total sleep deprivation followed by sleep phase advance and bright light therapy in drug-resistant mood disorders. J Affect Disord. 2013;144(1–2):28–33. doi: 10.1016/j.jad.2012.06.022
  • Benedetti F, Riccaboni R, Locatelli C, et al. Rapid treatment response of suicidal symptoms to lithium, sleep deprivation, and light therapy (chronotherapeutics) in drug-resistant bipolar depression. J Clin Psychiatry. 2014;75(2):133–140. doi: 10.4088/JCP.13m08455
  • Kragh M, Larsen ER, Martiny K, et al. Predictors of response to combined wake and light therapy in treatment-resistant inpatients with depression. Chronobiol In. 2018;35(9):1209–1220. doi: 10.1080/07420528.2018.1468341
  • Sikkens D, Riemersma-Van der Lek RF, Meesters Y, et al. Combined sleep deprivation and light therapy: clinical treatment outcomes in patients with complex unipolar and bipolar depression. J Affect Disord. 2019;246:727–730. doi: 10.1016/j.jad.2018.12.117
  • Mania I, Kaur J. Bright light therapy and rTMS; novel combination approach for the treatment of depression. Brain Stimul. 2019;12(5):1338–1339. doi: 10.1016/j.brs.2019.06.002
  • Moeller SB, Gbyl K, Hjorthøj C, et al. Treatment of difficult-to-treat depression – clinical guideline for selected interventions. Nord J Psychiatry. 2022;76(3):177–188. doi: 10.1080/08039488.2021.1952303
  • Kelly CA, Freeman KB, Schumacher JA. Treatment-resistant depression with anhedonia: integrating clinical and preclinical approaches to investigate distinct phenotypes. Neurosci Biobehav Rev. 2022;136:104578. doi: 10.1016/j.neubiorev.2022.104578
  • Sagud M, Tudor L, Šimunić L, et al. Physical and social anhedonia are associated with suicidality in major depression, but not in schizophrenia. Suicide & Life Threat Behav. 2021;51(3):446–454. doi: 10.1111/sltb.12724
  • Vlenterie R, van Gelder MMHJ, Anderson HR, et al. Associations between maternal depression, antidepressant use during pregnancy, and adverse pregnancy outcomes: an individual participant data meta-analysis. Obstet Gynecol. 2021;138(4):633–646. doi: 10.1097/AOG.0000000000004538
  • Li K, Zhou G, Xiao Y, et al. Risk of suicidal behaviors and antidepressant exposure among children and adolescents: a meta-analysis of observational studies. Front Psychiatry. 2022;13:880496. doi: 10.3389/fpsyt.2022.880496
  • Niederhofer H, von Klitzing K. Bright light treatment as add-on therapy for depression in 28 adolescents: a randomized trial. Prim Care Companion CNS Disord. 2011;13(6):CC.11m01194. doi: 10.4088/PCC.11m01194
  • Berger C, Dück A, Gest S, et al. Possible effects of bright light therapy on electroencephalogram-vigilance in the treatment of depression in adolescents: a pilot study. Front Psychiatry. 2022;13:820090. doi: 10.3389/fpsyt.2022.820090
  • Uzun S, Sagud M, Pivac N. Biomarkers of depression associated with comorbid somatic diseases. Psychiatry Danub. (2021). 33(4):463–470.
  • Hoffelt C, Gross T. A review of significant pharmacokinetic drug interactions with antidepressants and their management. Ment Health Clin. 2016;6(1):35–41. doi: 10.9740/mhc.2016.01.035
  • Wolff J, Reißner P, Hefner G, et al. Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders. PLoS One. 2021;16(7):e0255192. doi: 10.1371/journal.pone.0255192
  • Sagud M, Vuksan Cusa B, Mihaljevic-Peles A. Antidepressants in the elderly population. Socijalna psihijatrija. 2019;47(3):335–343. doi: 10.24869/spsih.2019.335
  • Eisenberg MJ, Habib B, Alcaraz M, et al. Bright light therapy for depressive symptoms in hospitalized cardiac patients: a randomized controlled pilot trial. PLoS One. 2020;15(3):e0230839. doi: 10.1371/journal.pone.0230839
  • Huang HT, Huang TW, Hong CT. Bright light therapy for Parkinson disease: a literature review and meta-analysis of randomized controlled trials. Biology. 2021;10(11):1205. doi: 10.3390/biology10111205
  • Lin F, Su Y, Weng Y, et al. The effects of bright light therapy on depression and sleep disturbances in patients with Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials. Sleep Med. 2021;83:280–289. doi: 10.1016/j.sleep.2021.03.035
  • Rutten S, Vriend C, Smit JH, et al. Bright light therapy for depression in Parkinson disease: a randomized controlled trial. Neurology. 2019;92(11):e1145–e1156. doi: 10.1212/WNL.0000000000007090
  • Qu Y, Zhuang L, Zhang H, et al. The effects of light therapy for depression in dementia: a systematic review and meta-analysis. J Alzheimers Dis. 2023;93(4):1223–1235. doi: 10.3233/JAD-221204
  • Sagud M, Tudor L, Pivac N. Personalized treatment interventions: nonpharmacological and natural treatment strategies in Alzheimer’s disease. Expert Rev Neurother. 2021;21(5):571–589. doi: 10.1080/14737175.2021.1906223
  • Elliott JE, McBride AA, Balba NM, et al. Feasibility and preliminary efficacy for morning bright light therapy to improve sleep and plasma biomarkers in US veterans with TBI. A prospective, open-label, single-arm trial. PLoS One. 2022;17(4):e0262955. doi: 10.1371/journal.pone.0262955
  • Srisurapanont K, Samakarn Y, Kamklong B, et al. Efficacy and acceptability of blue-wavelength light therapy for post-TBI behavioral symptoms: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2022;17(10):e0274025. doi: 10.1371/journal.pone.0274025
  • Praschak-Rieder N, Neumeister A, Hesselmann B, et al. Suicidal tendencies as a complication of light therapy for seasonal affective disorder: a report of three cases. J Clin Psychiatry. 1997;58: 389–392. doi: 10.4088/jcp.v58n0903
  • Dallaspezia S, Benedetti F. Antidepressant light therapy for bipolar patients: a meta-analyses. J Affect Disord. 2020;274:943–948. doi: 10.1016/j.jad.2020.05.104
  • Terman M, Terman JS. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr. 2005;10(8):647–663. doi: 10.1017/s1092852900019611
  • Lu X, Liu C, Shao F. Phototherapy improves cognitive function in dementia: a systematic review and meta-analysis. Brain Behav. 2023;13(5):e2952. doi: 10.1002/brb3.2952
  • Artemenko A.R, Filatova E, Vorobyeva YD, et al. Migraine and light: a narrative review. Headache. 2022;62(1):4–10. doi: 10.1111/head.14250
  • Lin TH, Yang CC, Lee SY, et al. The effect of bright light therapy in migraine patients with sleep disturbance: a prospective, observational cohort study protocol. Front Aging Neurosci. 2023;14:1041076. doi: 10.3389/fnagi.2022.1041076
  • Benedetti F, Barbini B, Fulgosi MC, et al. Combined total sleep deprivation and light therapy in the treatment of drug-resistant bipolar depression: acute response and long-term remission rates. J Clin Psychiatry. 2005;66(12):1535–1540. doi: 10.4088/JCP.v66n1207
  • Gottlieb JF, Benedetti F, Geoffroy PA, et al. The chronotherapeutic treatment of bipolar disorders: a systematic review and practice recommendations from the ISBD task force on chronotherapy and chronobiology. Bipolar Disord. 2019;21(8):741–773. doi: 10.1111/bdi.12847
  • Loving RT, Kripke DF, Shuchter SR. Bright light augments antidepressant effects of medication and wake therapy. Depress Anxiety. 2002;16(1):1–3. doi: 10.1002/da.10036
  • Spravato, INN-esketamine. Summary of product characteristics [Internet]. European Medicines Agency; [cited 2023 Jun 19]. Available from: https://www.ema.europa.eu/en/documents/product-information/spravato-epar-product-information_en.pdf
  • Carvalho AF, Sharma MS, Brunoni AR, et al. The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom. 2016;85(5):270–288. doi: 10.1159/000447034
  • American Psychiatric Association. Clinical practice guideline for the treatment of depression across three age cohorts [Internet]. Arlington (VA): American Psychiatric Association; 2019. [cited 2023 Jun19]. Available from: https://www.apa.org/depression-guideline
  • Geoffroy PA, Hoertel N, Etain B, et al. Insomnia and hypersomnia in major depressive episode: prevalence, sociodemographic characteristics and psychiatric comorbidity in a population-based study. J Affect Disord. 2018;226:132–141. doi: 10.1016/j.jad.2017.09.032
  • Tsuno N, Besset A, Ritchie K. Sleep and depression. J Clin Psychiatry. 2005;66(10):1254–1269. doi: 10.4088/jcp.v66n1008
  • Menculini G, Verdolini N, Murru A, et al. Depressive mood and circadian rhythms disturbances as outcomes of seasonal affective disorder treatment: a systematic review. J Affect Disord. 2018;241:608–626. doi: 10.1016/j.jad.2018.08.071
  • Benedetti F. Rate of switch from bipolar depression into mania after morning light therapy: a historical review. Psychiatry Res. 2018;261:351–356. doi: 10.1016/j.psychres.2018.01.013
  • Leibenluft E, Turner EH, Feldman-Naim S, et al. Light therapy in patients with rapid cycling bipolar disorder: preliminary results. Psychopharmacol Bull. 1995;31(4):705–710.
  • Wirz-Justice A, Benedetti F, Terman. 2013. Chronotherapeutics for affective disorders. 2nd ed. Basel (Switzerland): S. Karger AG; doi:10.1159/isbn.978-3-8055-9121-8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.